Prospettive Sociali e Sanitarie

Judith G. Rabkin, Martin C. McElhiney, Richard Rabkin, Patrick J. McGrath, and Stephen J. Ferrando
Placebo-Controlled Trial of Dehydroepiandrosterone (DHEA) for Treatment of Nonmajor Depression in Patients With
HIV/AIDS 59-66
Herbert Hendin, Ann Pollinger Haas, John T. Maltsberger, Bethany Koestner, and Katalin Szanto
Problems in Psychotherapy With Suicidal Patients 67-72
Bonnie P. Taylor, Gerard E. Bruder, Jonathan W. Stewart, Patrick J. McGrath, Jeffrey Halperin, Howard Ehrlichman,
and Frederic M. Quitkin
Psychomotor Slowing as a Predictor of Fluoxetine Nonresponse in Depressed Outpatients 73-78
Raymond Rosen, Ridwan Shabsigh, Mark Berber, Pierre Assalian, Mathew Menza, Luis Rodriguez-Vela, Robert Porto,
Keith Bangerter, Monica Seger, Francesco Montorsi, and The Vardenafil Study Site Investigators
Efficacy and Tolerability of Vardenafil in Men With Mild Depression and Erectile Dysfunction: The Depression-
Related Improvement With Vardenafil for Erectile Response Study 79-87.
Paul B. Fitzgerald, Jessica Benitez, Anthony de Castella, Z. Jeff Daskalakis, Timothy L. Brown, and Jayashri Kulkarni
A Randomized, Controlled Trial of Sequential Bilateral Repetitive Transcranial Magnetic Stimulation for Treatment-
Resistant Depression 88-94
Roger T. Mulder, Peter R. Joyce, Christopher M.A. Frampton, Suzanne E. Luty, and Patrick F. Sullivan
Six Months of Treatment for Depression: Outcome and Predictors of the Course of Illness 95-100
Mark Olfson, Steven C. Marcus, Michael Tedeschi, and George J. Wan
Continuity of Antidepressant Treatment for Adults With Depression in the United States 101-108
Kenneth S. Kendler, Margaret Gatz, Charles O. Gardner, and Nancy L. Pedersen
A Swedish National Twin Study of Lifetime Major Depression 109-114
Kenneth S. Kendler, Charles O. Gardner, and Carol A. Prescott
Toward a Comprehensive Developmental Model for Major Depression in Men 115-124
Katherine E. Watkins, Susan M. Paddock, Lily Zhang, and Kenneth B. Wells
Improving Care for Depression in Patients With Comorbid Substance Misuse 125-132
Misty Richards, David R. Rubinow, Robert C. Daly, and Peter J. Schmidt
Premenstrual Symptoms and Perimenopausal Depression 133-137
Peter de Jonge, Johan Ormel, Rob H.S. van den Brink, Joost P. van Melle, Titia A. Spijkerman, Astrid Kuijper, Dirk J.
van Veldhuisen, Maarten P. van den Berg, Adriaan Honig, Harry J.G.M. Crijns, and Aart H. Schene
Symptom Dimensions of Depression Following Myocardial Infarction and Their Relationship With Somatic Health
Status and Cardiovascular Prognosis 138-144.
Ada M. Loughhead, Angela D. Fisher, D. Jeffrey Newport, James C. Ritchie, Michael J. Owens, C. Lindsay DeVane,
and Zachary N. Stowe
Antidepressants in Amniotic Fluid: Another Route of Fetal Exposure 145-147.
Mark Zimmerman, Joseph B. McGlinchey, Michael A. Posternak, Michael Friedman, Naureen Attiullah, and Daniela
Boerescu
How Should Remission From Depression Be Defined? The Depressed Patient’s Perspective 148-150
Brief Reports:
Frank G. Dowling, Gene Moynihan, Bill Genet, and Jonathan Lewis A Peer-Based Assistance Program for Officers
With the New York City Police Department: Report of the Effects of Sept. 11, 2001 151-153
Carlos A. Zarate, Jr., Jaskaran B. Singh, Jorge A. Quiroz, Georgette De Jesus, Kirk K. Denicoff, David A.
Luckenbaugh, Husseini K. Manji, and Dennis S. Charney A Double-Blind, Placebo-Controlled Study of Memantine in
the Treatment of Major Depression 153-155
Jennifer D. Lundgren, Kelly C. Allison, Scott Crow, John P. O’Reardon, Kelly C. Berg, Juliette Galbraith, Nicole S.
Martino, and Albert J. Stunkard Prevalence of the Night Eating Syndrome in a Psychiatric Population 156-158
Communications and Updates